EP2381803A1 - Rauchloses, lösbares komprimiertes tabakprodukt - Google Patents

Rauchloses, lösbares komprimiertes tabakprodukt

Info

Publication number
EP2381803A1
EP2381803A1 EP09812420A EP09812420A EP2381803A1 EP 2381803 A1 EP2381803 A1 EP 2381803A1 EP 09812420 A EP09812420 A EP 09812420A EP 09812420 A EP09812420 A EP 09812420A EP 2381803 A1 EP2381803 A1 EP 2381803A1
Authority
EP
European Patent Office
Prior art keywords
tobacco
dissolvable compressed
smokeless dissolvable
component
tobacco product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP09812420A
Other languages
English (en)
French (fr)
Other versions
EP2381803B1 (de
Inventor
Håkan BIVEHED
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris Products SA
Original Assignee
Philip Morris Products SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products SA filed Critical Philip Morris Products SA
Priority to EP09812420.9A priority Critical patent/EP2381803B1/de
Priority to PL09812420T priority patent/PL2381803T3/pl
Publication of EP2381803A1 publication Critical patent/EP2381803A1/de
Application granted granted Critical
Publication of EP2381803B1 publication Critical patent/EP2381803B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/183—Treatment of tobacco products or tobacco substitutes sterilization, preservation or biological decontamination
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/20—Biochemical treatment

Definitions

  • the present invention relates to an oral smokeless dissolvable compressed tobacco product.
  • a number of oral smokeless non-dissolvable tobacco products that include an insoluble residual component that is disposed of by a consumer after use are known in the art.
  • Known smokeless non-dissolvable tobacco products include: plug, twist, and loose leaf chewing tobacco; dry snuff; moist snuff, which typically contains finely cut fermented moist tobacco; loose or portioned snus, which typically contains finely ground moist tobacco; and tobacco- containing chewing gum.
  • a number of oral smokeless dissolvable tobacco products that dissolve in the mouth of a consumer are also known.
  • smokeless dissolvable compressed tobacco products in the form of pills, tablets and lozenges which comprise powdered or ground tobacco together with other ingredients.
  • Raw, unprocessed tobacco may contain increased levels of viable bacteria.
  • smokeless dissolvable compressed tobacco products dissolve and the tobacco in such products is ingested by the consumer it would be desirable to provide an improved method for treating a smokeless dissolvable compressed tobacco product for oral use.
  • a smokeless dissolvable compressed tobacco product comprising: a pasteurised tobacco component, wherein the substantially aseptic smokeless dissolvable compressed tobacco product has a total aerobic microbial count of less than 2 log cfu/g.
  • a method of making a smokeless dissolvable compressed tobacco product having a total aerobic microbial count of less than 2 log cfu/g comprises: pasteurising a tobacco component to reduce the total aerobic microbial count to less than 2 log cfu/g and the total yeast and mould count to less than 2 log cfu/g; mixing the pasteurised tobacco component with one or more non-tobacco components; and compressing the pasteurised tobacco component and one or more non- tobacco components to form a smokeless dissolvable compressed tobacco product.
  • the total aerobic microbial count is measured in accordance with the Nordic Committee on Food Analysis (NMKL) method No 86, 4.
  • NMKL method No 98, 4. Ed., 2005 The NMKL method No 86, 4. Ed., 2006 is used to determine the aerobic plate count by preparing a dilution series of sample material according to general microbiological principles, followed by pour-plating into an agar medium in Petri dishes. In this method, the samples are incubated under aerobic conditions at either 30 0 C for 3 days, 20°C for 3 days, or 6.5°C for 10 days. In the NMKL method No 98, 4.
  • the yeast and mould count is determined by surface inoculation of appropriate dilution series on dichloran rose bengal agar (DRBC), dichloran glycerol agar (DG18) or oxytetracykline glucose yeast extract agar (OGYE) dependent on which matrix are analysed.
  • DRBC dichloran rose bengal agar
  • DG18 dichloran glycerol agar
  • OYE oxytetracykline glucose yeast extract agar
  • the tobacco component may be pasteurised using any suitable technique provided that the pasteuriation parameters such as temperature and time are sufficient to reduce the total aerobic microbial count of the tobacco component to less than 2 log cfu/g and the total yeast and mold count of the tobacco component to less than 2 log cfu/g to render the tobacco component substantially aseptic.
  • Suitable pasteurisation techniques include, but are not limited to, single hot steam injection, repeated hot steam injection and indirect heating.
  • the tobacco component is pasteurised by hot steam injection, more preferably by repeated hot steam injection.
  • the step of pasteurising the tobacco component comprises direct heating of the tobacco by hot steam injection to a temperature of between about 100 0 C and about 12O 0 C for a period of between about 1 minute and about 30 minutes. More preferably, the step of pasteurising the tobacco component comprises direct heating of the tobacco component by repeated hot steam injection to temperatures of at least about 100 0 C.
  • the heat treament of the tobacco component during pasteurisation advantageously results in the formation of tobacco-derived flavourings.
  • the tobacco component may be pasteurised together with water.
  • the tobacco component may be pasteurised with one or more other additives approved for use in the food industry, including, but not limited to, sodium chloride, sodium carbonate, potassium carbonate, propylene glycol, glycerol and combinations thereof.
  • the pH of the pasteurised tobacco component may be adjusted prior to compressing the pasteurised tobacco component and one or more non-tobacco components to form the smokeless dissolvable compressed tobacco product.
  • the pH of the pasteurised tobacco component is adjusted to between about 7.5 and about 8.9.
  • the pH of the pasteurised tobacco component may be adjusted through the addition of one or more acidity regulators.
  • Suitable acidity regulators approved for use in the food industry are known in the art and include, but are not limited to: alkali carbonates, such as sodium carbonate and potassium carbonate; calcium carbonate; alkali hydroxides, such as sodium hydroxide and potassium hydroxide; calcium hydroxide; magnesium hydroxide; and combinations thereof.
  • the pH of the pasteurised tobacco component is adjusted prior to mixing the pasteurised tobacco component with the one or more non-tobacco components.
  • the pH of the pasteurised tobacco component may be adjusted by mixing the pasteurised tobacco component with one or more non-tobacco components comprising at least one acidity regulator or buffering agent.
  • the tobacco component may comprise one or more of tobacco lamina, tobacco stem, expanded tobacco and reconstituted tobacco.
  • the tobacco component may comprise a blend of two or more different types of tobacco.
  • the tobacco component may comprise a blend of two or more of different types of tobacco selected from the group consisting of Virginia, Burley, Maryland, Nicotiana rustica and oriental tobacco.
  • the tobacco component may comprise a single type of tobacco.
  • the tobacco component may comprise tobacco that has been one or more of dried, aged, flue-cured, air-cured, fire-cured, sun-cured, shredded, powdered and ground.
  • the tobacco component comprises air-cured tobacco, sun-cured tobacco, dark air-cured tobacco or a combination thereof.
  • the tobacco component comprises particulate tobacco. More preferably, the tobacco component comprises powdered tobacco, ground tobacco or a combination thereof.
  • the particulate tobacco may have any suitable average particle size.
  • the particulate tobacco may have an average particle size of less than about 1 mm, less than about 0.5 mm or less than about 0.1 mm.
  • the particulate tobacco has an average particle size of between about 100 nm and about 1 mm, more preferably of between about 100 nm and about 0.5 mm.
  • the tobacco may be ground and sieved in a typical manner in order to obtain a desired particle size.
  • the smokeless dissolvable compressed tobacco product further comprises one or more non-tobacco components.
  • smokeless dissolvable compressed tobacco products according to the invention may further comprise one or more non-tobacco components approved for use in the food industry selected from the group consisting of: acidity regulators, buffering agents, fillers, binders, gelling agents, lubricants, anti-adherents, glidants, disintegration agents, sweeteners, flavourants, taste enhancers and colourants.
  • the tobacco component may be dry blended or otherwise mixed with the one or more non-tobacco components.
  • the tobacco component and one or more non-tobacco components may be ground together or mixed in a twisting powder mixer.
  • the tobacco component may be present in the smokeless dissolvable compressed tobacco product in an amount of between about 0.5% to about 60% of the dry weight of the compressed tobacco product.
  • the amount of the tobacco component may be selected as a function of, for example, the desired nicotine content or the desired flavour or other organoleptic properties of the smokeless dissolvable compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product comprises: at least one binder or filler; at least one lubricant, anti- adherent or glidant; at least one acidity regulator; at least one flavourant; and at least one sweetener.
  • the smokeless dissolvable compressed tobacco product also comprises one or more of a gelling agent, a taste enhancer, a colourant and a disintegration agent.
  • the smokeless dissolvable compressed tobacco product comprises at least one binder or filler.
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more gelling agents.
  • gelling agent is used to refer to any component that affects the mouth feel of the smokeless dissolvable compressed tobacco product when dissolved in the mouth of a consumer.
  • Suitable binders, fillers and gelling agents include, but are not limited to: non-tobacco plant fibres; starches, including pre-gelatinized starch; gums, including natural gums, such as xanthan gum, gum, acacia, gum arabic, guar gum, locust bean gum and sodium alginate; pectins: gelatine: agar: carrageenan; pullulan; microcrystalline cellulose; methyl cellulose; carboxymethyl cellulose; dextrins, including maltodextrin; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; glucose; lactose; sucrose; polyvidone; calcium sulfate dihydrate; and combinations thereof.
  • non-tobacco plant fibres starches, including pre-gelatinized starch
  • gums including natural gums, such as xanthan gum, gum,
  • the smokeless dissolvable compressed tobacco product comprises microcrystalline cellulose, which functions as a binder and a filler.
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more lubricants, anti-adherents, glidants or combinations thereof.
  • lubricant anti-adherent and glidant are used to refer to any component that facilitates manufacturing of the smokeless dissolvable compressed tobacco product by reducing friction, reducing adhesion, or otherwise improving flow properties. It will be appreciated that a single non-tobacco component may perform the functions of one or more of a lubricant, an anti- adherent and a glidant.
  • Suitable lubricants, anti-adherents and glidants include, but are not limited to: stearates, including magnesium stearate, calcium stearate, sodium stearate, zinc stearate, and derivatives thereof, including sodium stearyl fumarate; fatty acids, including stearic acid; silicates, including magnesium silicates and calcium silicates; starch; lauryl sulfates, including magnesium lauryl sulfate and sodium lauryl sulfate; polyethylene glycol; and silica aerogels, including colloidal fumed silica.
  • the one or more lubricants, anti-adherents, glidants or combinations thereof may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 5% of the dry weight of the compressed tobacco product.
  • the one or more lubricants, anti-adherents, glidants or combinations thereof are present in the smokeless dissolvable compressed tobacco product in an amount of less than about 1% of the dry weight of the compressed tobacco product, more preferably in an amount of about 0.2% of the dry weight of the compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more disintegrants.
  • disintegrant is used to refer to any component that facilitates breakup or disintegration of the smokeless dissolvable compressed tobacco product when placed in a consumer's mouth.
  • Suitable disintegrants include, but are not limited to: starches, including pregelatinised starch; sodium starch glycolate; sodium alginate; croscarmellose sodium; crosslinked polyvinylpyrrolidone, including crospovidone; sodium carboxymethyl cellulose; calcium carboxymethyl cellulose; sodium bicarbonate; and calcium carbonate.
  • the one or more disintegrants maybe present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 1% to about 15% of the dry weight of the compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more sweeteners.
  • Smokeless dissolvable compressed tobacco products according to the invention may include natural sweeteners, artificial sweeteners or combinations thereof.
  • Suitable natural and artificial sweeteners are known in the art and include, but are not limited to: monosaccharides, such as glucose, fructose, ribose xylose and invert sugar; disaccharides, such as lactose, maltose and sucrose; sugar alcohols, such as erythritol, xylitol mannitol, sorbitol, isomalt, maltitol and lactitol; and artificial sweeteners, such as sucralose, aspartame, saccharin, acesulfame K, and cyclamate,
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more flavourants.
  • Smokeless dissolvable compressed tobacco products according to the invention may include natural flavourants, artificial flavourants or combinations thereof.
  • the one or more flavourants may be added in encapsulated or non-encapsulated form.
  • Suitable natural and artificial flavourants include, but are not limited to, peppermint, spearmint, wintergreen, menthol, eucalyptus oil, angelica, anise, anethole, carvone, vanillin, vanilla, basil oil, cardamom, cassia, cinnamon, clove, cocoa, coriander oil, fennel oil, fenugreek, ginger, lemon grass, liquorice, nutmeg, palmarosa oil, sage oil, acacia, amber, clary, geranium, jasmine, juniper berry, lavender oil, magnolia, oak moss, orris root, osmanthus, rose oil, sandalwood, bergamot oil, lemon oil, lime oil, orange oil, fruit extracts, fruit flavouring, almond, coconut, chocolate, coffee, tea, arrack, rum, cognac, whisky, and gin.
  • the one or more flavourants may be present in the smokeless dissolvable compressed tobacco product in an amount of, for example, between about 0.1% to about 4% of the dry weight of the compressed tobacco product.
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more taste enhancers such as, for example, sodium chloride or ammonium chloride.
  • the smokeless dissolvable compressed tobacco product may optionally comprise one or more colourants to, for example, indicate or reflect the flavour or brand of the compressed tobacco product or otherwise enhance its aesthetic appearance.
  • smokeless dissolvable compressed tobacco products may comprise multifunctional non-tobacco components that perform two or more of the functions previously described above.
  • the smokeless dissolvable compressed tobacco product may comprise a multifunctional non-tobacco component that functions as at least two of: (i) a binder or filler; (ii) a lubricant, anti-adherent or glidant; and (iii) a disintegrant.
  • the smokeless dissolvable compressed tobacco product may comprise pre-gelatinised starch that functions as a binder, lubricant and disintegrant.
  • Smokeless dissolvable compressed tobacco products according to the invention may also comprise mutlifunctional non-tobacco components that perform two or more other functions.
  • the smokeless dissolvable compressed tobacco product may comprise a sugar alcohol that acts as a binder and a sweetner, or colloidal fumed silica that acts as a glidant and a desiccant.
  • suitable known desiccants such as, for example, magnesium sulfate may also be included in smokeless dissolvable compressed tobacco products according to the invention to control the moisture content thereof.
  • the pasteurised tobacco component may be dry blended with one or more non-tobacco components and then directly compressed in a typical manner to form the smokeless dissolvable compressed tobacco product.
  • the pasteurised tobacco component and one or more non-tobacco components maybe be directly compressed using, for example, a tablet press having a single die and punch arrangement or a rotary tablet press having multiple dies.
  • the pasteurised tobacco component may optionally be wet granulated in a typical manner using, for example, a fluid bed granulator.
  • the compression forces used to form the smokeless dissolvable compressed tobacco product may be selected based on a number of factors. These factors include: the type of apparatus employed to compress the tobacco component and one or more non-tobacco components; the size of the smokeless dissolvable compressed tobacco product; the desired physical and mechanical properties of the smokeless dissolvable compressed tobacco product, including but not limited to the hardness, friability, disintegration or dissolution characteristics; and the desired appearance of the compressed smokeless dissolvable compressed tobacco product.
  • smokeless dissolvable compressed tobacco products according to the invention may be produced having a hardness of between about 2 N and about 300 N.
  • smokeless dissolvable compressed tobacco products according to the invention may be produced that dissolve in the mouth of an average consumer within about 5 minutes to about 45 minutes.
  • smokeless dissolvable compressed tobacco products according to the invention dissolve in the mouth of an average consumer within about 5 minutes to about 15 minutes.
  • smokeless dissolvable compressed tobacco products according to the invention which dissolve in the mouth of an average consumer within about 30 minutes to about 45 minutes and which can be sucked by a consumer and then "parked" between their cheek and gum may be advantageously produced.
  • one or more surfaces of the formed smokeless dissolvable compressed tobacco product may be embossed or debossed.
  • the formed smokeless dissolvable compressed tobacco product may be at least partially coated in a typical manner using, for example, a pan coater.
  • Smokeless dissolvable compressed tobacco products according to the invention may be produced in a variety of different shapes.
  • Figs. 1-12 show: (a) perspective views; (b) side views; and (c) top views of examples of different shaped smokeless dissolvable compressed tobacco products according to the invention.
  • Smokeless dissolvable compressed tobacco products according to the invention may also be produced in a variety of different sizes.
  • smokeless dissolvable compressed tobacco products according to the invention may have a diameter of from about 2 mm to about 30 mm and a weight of from about 0.1 g to about 3.0 g.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Manufacture Of Tobacco Products (AREA)
EP09812420.9A 2009-01-28 2009-12-30 Rauchloses, auflösbares, verdichtetes tabakprodukt Active EP2381803B1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09812420.9A EP2381803B1 (de) 2009-01-28 2009-12-30 Rauchloses, auflösbares, verdichtetes tabakprodukt
PL09812420T PL2381803T3 (pl) 2009-01-28 2009-12-30 Bezdymny rozpuszczalny prasowany wyrób tytoniowy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09250218A EP2213181A1 (de) 2009-01-28 2009-01-28 Rauchloses, auflösbares, verdichtetes Tabakprodukt
PCT/EP2009/009323 WO2010086010A1 (en) 2009-01-28 2009-12-30 Smokeless dissolvable compressed tobacco product
EP09812420.9A EP2381803B1 (de) 2009-01-28 2009-12-30 Rauchloses, auflösbares, verdichtetes tabakprodukt

Publications (2)

Publication Number Publication Date
EP2381803A1 true EP2381803A1 (de) 2011-11-02
EP2381803B1 EP2381803B1 (de) 2014-06-04

Family

ID=40983458

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09250218A Withdrawn EP2213181A1 (de) 2009-01-28 2009-01-28 Rauchloses, auflösbares, verdichtetes Tabakprodukt
EP09812420.9A Active EP2381803B1 (de) 2009-01-28 2009-12-30 Rauchloses, auflösbares, verdichtetes tabakprodukt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP09250218A Withdrawn EP2213181A1 (de) 2009-01-28 2009-01-28 Rauchloses, auflösbares, verdichtetes Tabakprodukt

Country Status (15)

Country Link
US (1) US20100275936A1 (de)
EP (2) EP2213181A1 (de)
JP (1) JP2012516137A (de)
KR (1) KR101779615B1 (de)
BR (1) BRPI0924206A2 (de)
CA (1) CA2737323C (de)
DK (1) DK2381803T3 (de)
EC (1) ECSP11011291A (de)
MX (1) MX2011003882A (de)
MY (1) MY159762A (de)
PL (1) PL2381803T3 (de)
RU (1) RU2011115844A (de)
TW (1) TWI513413B (de)
UA (1) UA100473C2 (de)
WO (1) WO2010086010A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD744160S1 (en) * 2005-10-18 2015-11-24 Swedish Match North Europe Ab Snuff box
USD735054S1 (en) 2007-11-15 2015-07-28 Swedish Match North Europe Ab Snuff box with snuff bags
EP2557947A1 (de) 2010-04-14 2013-02-20 Altria Client Services Inc. Vorgeformtes rauchloses tabakprodukt
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US11116237B2 (en) * 2010-08-11 2021-09-14 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US9775376B2 (en) * 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US9204667B2 (en) * 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
US9468233B2 (en) 2010-12-10 2016-10-18 Altria Client Services Llc Smokeless tobacco packaging system and method
WO2012133365A1 (ja) * 2011-03-30 2012-10-04 日本たばこ産業株式会社 口腔用たばこ及びその製造方法
WO2013192413A1 (en) * 2012-06-20 2013-12-27 Mishra Munmaya K Smokeless tobacco comprising lipid granules
US9402414B2 (en) * 2013-03-14 2016-08-02 Altria Client Services Llc Smokeless tobacco article
US20150096574A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tobacco tablet
MX2019013606A (es) * 2017-05-24 2020-08-20 Philip Morris Products Sa Articulo generador de aerosol calentado que comprende material botanico homogeneizado.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739600A (en) * 1955-07-01 1956-03-27 American Mach & Foundry Tobacco treatment
US4513756A (en) * 1983-04-28 1985-04-30 The Pinkerton Tobacco Company Process of making tobacco pellets
GB2142822B (en) * 1983-06-29 1987-02-11 Alec Stanley Walter Shaw Nicotine lozenges
US4624269A (en) * 1984-09-17 1986-11-25 The Pinkerton Tobacco Company Chewable tobacco based product
US5372149A (en) * 1992-03-25 1994-12-13 Roth; David S. Sterilization process in the manufacturing of snuff
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US20040020503A1 (en) * 2001-05-01 2004-02-05 Williams Jonnie R. Smokeless tobacco product
US6668839B2 (en) * 2001-05-01 2003-12-30 Jonnie R. Williams Smokeless tobacco product
AP1510A (en) * 2001-05-01 2005-12-17 Jonnie R Williams Smokeless tobacco product.
JP4931596B2 (ja) * 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
US8627828B2 (en) * 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7918231B2 (en) * 2006-01-31 2011-04-05 U.S. Smokeless Tobacco Company Llc Tobacco articles and methods
US7810507B2 (en) * 2006-02-10 2010-10-12 R. J. Reynolds Tobacco Company Smokeless tobacco composition
US7946296B2 (en) * 2006-05-26 2011-05-24 Philip Morris Usa Inc. Dissolvable tobacco film strips and method of making the same
US20080029116A1 (en) * 2006-08-01 2008-02-07 John Howard Robinson Smokeless tobacco
DE602007010944D1 (de) * 2006-08-01 2011-01-13 Reynolds Tobacco Co R Rauchloser tabak
JP2010511611A (ja) * 2006-12-01 2010-04-15 シマ ラブス インク． 口腔経粘膜ニコチン剤形
TW200901904A (en) * 2007-02-23 2009-01-16 Us Smokeless Tobacco Co Novel tobacco compositions and methods of making
US9125434B2 (en) * 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
US8336557B2 (en) * 2007-11-28 2012-12-25 Philip Morris Usa Inc. Smokeless compressed tobacco product for oral consumption
SI2219479T1 (sl) * 2007-12-21 2019-01-31 Swedish Match North Europe Ab Tobačni ali ne-tobačni izdelek, ki vsebuje magnezijev karbonat

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2010086010A1 *

Also Published As

Publication number Publication date
EP2381803B1 (de) 2014-06-04
CA2737323A1 (en) 2010-08-05
WO2010086010A1 (en) 2010-08-05
MY159762A (en) 2017-01-31
BRPI0924206A2 (pt) 2016-01-19
EP2213181A1 (de) 2010-08-04
KR101779615B1 (ko) 2017-10-10
TW201036559A (en) 2010-10-16
TWI513413B (zh) 2015-12-21
RU2011115844A (ru) 2013-03-10
DK2381803T3 (da) 2014-07-14
KR20110110762A (ko) 2011-10-07
CA2737323C (en) 2016-06-21
US20100275936A1 (en) 2010-11-04
ECSP11011291A (es) 2011-09-30
UA100473C2 (uk) 2012-12-25
PL2381803T3 (pl) 2014-11-28
JP2012516137A (ja) 2012-07-19
MX2011003882A (es) 2011-05-19

Similar Documents

Publication Publication Date Title
CA2737323C (en) Smokeless dissolvable compressed tobacco product
US10568355B2 (en) Smokeless tobacco pastille
US11612183B2 (en) Protein-enriched tobacco composition
US10925309B2 (en) Tobacco lozenge
EP3518691B1 (de) Tabakkügelchen
EP2512271B1 (de) Tabakprodukt und verfahren zu seiner herstellung
EP2613653B1 (de) Rauchloses tabakprodukt mit brauseformulierung
US11617744B2 (en) Moist oral compositions
US20210169132A1 (en) Oral composition including gels
US20110139164A1 (en) Tobacco Product And Method For Manufacture
EP3052081B1 (de) Lutschtablette
US20210169788A1 (en) Oral product and method of manufacture
US20230270863A1 (en) Oral products with reduced irritation
US20210169785A1 (en) Oral compositions with reduced water activity
US20210169868A1 (en) Oral compositions with reduced water content
US20210169784A1 (en) Buffered oral compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130422

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140306

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 670520

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140615

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: BOVARD AG, CH

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20140710

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009024514

Country of ref document: DE

Effective date: 20140717

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NO

Ref legal event code: T2

Effective date: 20140604

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 670520

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140905

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

REG Reference to a national code

Ref country code: PL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141006

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141004

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009024514

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

26N No opposition filed

Effective date: 20150305

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009024514

Country of ref document: DE

Effective date: 20150305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141230

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20150831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141230

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20091230

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20151230

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140604

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20191122

Year of fee payment: 11

Ref country code: DK

Payment date: 20191227

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NO

Payment date: 20191223

Year of fee payment: 11

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20201231

REG Reference to a national code

Ref country code: NO

Ref legal event code: MMEP

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201230

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201230

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230529

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231220

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20231220

Year of fee payment: 15

Ref country code: NL

Payment date: 20231220

Year of fee payment: 15

Ref country code: DE

Payment date: 20231214

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20240101

Year of fee payment: 15